Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lynn Malec"'
Autor:
Margaret V. Ragni, Guy Young, Glaivy Batsuli, Emily Bisson, Shannon L. Carpenter, Stacy E. Croteau, Adam Cuker, Randall G. Curtis, Michael Denne, Bruce Ewenstein, Amber Federizo, Neil Frick, Kerry Funkhouser, Lindsey A. George, W. Keith Hoots, Shawn M. Jobe, Emily Krava, Christopher James Langmead, Roger J. Lewis, José López, Lynn Malec, Ziva Mann, Moses E. Miles, Emma Neely, Ellis J. Neufeld, Glenn F. Pierce, Steven W. Pipe, Lisa R. Pitler, Leslie Raffini, Kathaleen M. Schnur, Jordan A. Shavit
Publikováno v:
Expert Review of Hematology. 16:107-127
Autor:
Margaret V. Ragni, Scott Rothenberger, Robert Feldman, Danielle Nance, Andrew D Leavitt, Lynn Malec, Robert F. Sidonio, Jr., Eric H. Kraut, Joseph L Lasky, Claire S. Philipp, Dana E. Angelini, Rajiv K. Pruthi, Nina Hwang, Allison P. Wheeler, Roshni Kulkarni, Craig D. Seaman, Frederico Xavier, Nicoletta C Machin, Michael Meyer, Daniel Bellissimo, Kenneth J. Smith, Elizabeth P. Merricks, Timothy C. Nichols, Dana Ivanco, Deborah Vehec, Glory Koerbel, Andrew D. Althouse
Publikováno v:
Blood. 140:1413-1415
Autor:
Lynn Malec, An Van Damme, Anthony KC Chan, Mariya Spasova, Nisha Jain, Charlotte Sensinger, Jennifer Dumont, Stefan Lethagen, Manuel Carcao, Flora Peyvandi
Publikováno v:
Blood.
Inhibitor development remains a major challenge in factor VIII (FVIII) replacement therapy. verITI-8 is the first prospective study of a recombinant factor VIII Fc fusion protein (efmoroctocog alfa; rFVIIIFc) for first-time immune tolerance induction
Autor:
Shannon L Carpenter, Martin Chandler, Michael F Guerrera, Lynn Malec, Matthew Manuel, Michael Recht, Ulrike Reiss, Robert F. Sidonio, Jr., Cristina Tarango, Marijke Van den Berg, Michael Wang, Courtney D. Thornburg
Publikováno v:
Blood. 140:63-64
Publikováno v:
Journal of pediatric hematology/oncology. 45(1)
Children with cancer have an increased risk for developing a venous thromboembolism (VTE) during their treatment course. Direct oral anticoagulants (DOACs) represent a relatively new class of oral medications to treat VTE; however, data are limited t
Autor:
Kristen Corrao, Lynn Malec
Publikováno v:
The Hematologist. 19
Autor:
Christina M. Abrams, Julie Jaffray, Amy Stillings, Brian R. Branchford, Guy Young, Neil A. Goldenberg, Yasmina L. Abajas, John Fargo, Shelly Crary, Riten Kumar, Gary Woods, Shalu Narang, James Cooper, Mike Silvey, Kate Garland, Arash Mahajerin, Lori Luchtman‐Jones, Marcela Torres, Jordan Wright, Kristy Pahl, Katherine Armstrong, Chi Braunreiter, Nihal Bakeer, Anthony Sochet, Marie Hogan, Shveta Gupta, Christine Knoll, Kerry Hege, Beverly Schaefer, Arun Panigrahi, Courtney Thornburg, Kristin Shimano, Sanjay Ahuja, Angela Weyand, Alexander Boucher, Yasmina Abajas, Anjali Subbaswamy, Osman Khan, Colleen Druzgal, Deanna Maida, Allison Wheeler, Lynn Malec, Brian Branchford, Nicole Elena Kucine, Stephanie Prozora
Publikováno v:
Research and Practice in Thrombosis and Haemostasis. 6:e12793
Autor:
Lynn Malec
Publikováno v:
Clinics in perinatology. 47(1)
Anemia in the newborn period can be a diagnostic challenge. This article explores the diagnosis, work-up, and differential diagnosis of anemia in this patient population with a focus on anemia that is not related to blood loss or immune-mediated cond
Autor:
Lynn Malec, An Van Damme, Anthony Chan, Mariya Spasova, Nisha Jain, Charlotte Sensinger, Jennifer Dumont, Stefan Lethagen, Manuel Carcao, Flora Peyvandi
Publikováno v:
Blood. 138:LBA-5
Introduction: Inhibitor development is a major complication of factor VIII (FVIII) replacement therapy, affecting approximately 30% of people with severe hemophilia A (Peyvandi et al Lancet 2016). Inhibitor eradication is the standard of care to rest